Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Heart Transplantation

Free Subscription Articles published in J Thorac Cardiovasc Surg Retrieve available abstracts of 90 articles: HTML format

Single Articles

May 2026
1. BERG AR, Krishnan A, Heng EE, Hu S, et al
   Expanding access and rising complexity: Contemporary early outcomes in heart-liver transplantation for adult congenital heart disease.
   J Thorac Cardiovasc Surg. 2026;171:1090-1100.
   PubMed     Abstract available
   
   
   April 2026
2. WILLIAMS AM, Wang CC, Trahanas J, Lima B, et al
   Donor Heart Undersizing Impacts Early Hemodynamics But Not 1-Year Survival in Adult Heart Transplantation-A High-Volume Single Center 5-Year Experience.
   J Thorac Cardiovasc Surg. 2026 Apr 3:S0022-5223(26)00846.
   PubMed     Abstract available
   
   
   March 2026
3. WU Z, Luo B, Kong D, Liu H, et al
   Suppression of fibroblastic activity prolongs cardiac transplant survival through targeting their ATG5 expression.
   J Thorac Cardiovasc Surg. 2026 Mar 23:S0022-5223(26)00791.
   PubMed     Abstract available
   
   
   February 2026
4. IYANNA N, Woolley BE, Nasim U, Dorken-Gallastegi A, et al
   Association of Post-Transplant Dialysis and Survival Following Donation after Circulatory Death Heart Transplantation.
   J Thorac Cardiovasc Surg. 2026 Feb 23:S0022-5223(26)00165.
   PubMed     Abstract available
   
   
   
5. WILLIAMS AM, Wang CC, Ahmad A, Trahanas J, et al
   Prolonged Pulseless Electrical Activity Warm Ischemia Predicts Mortality and Graft Dysfunction in Donation after Circulatory Death Heart Transplant.
   J Thorac Cardiovasc Surg. 2026 Feb 3:S0022-5223(26)00093.
   PubMed     Abstract available
   
   
   
6. LI S, Nordick KV, Elsenousi AE, Hassan AM, et al
   Effect of cold storage solution on warm ischemia-induced myocardial plasma membrane damage and pyroptosis in human hearts from circulatory death donors.
   J Thorac Cardiovasc Surg. 2026;171:439-453.
   PubMed     Abstract available
   
   
   January 2026
7. WILLIAMS AM, Ahmad A, Bommareddi S, Lima B, et al
   10 degrees C Static Cold Storage Mitigates the Impact of Advanced Donor Age on Heart Transplant Recipient Outcomes.
   J Thorac Cardiovasc Surg. 2026 Jan 2:S0022-5223(25)01068.
   PubMed     Abstract available
   
   
   
8. CHAPPELL G, Mehdizadeh-Shrifi A, Turner D, Bondoc A, et al
   Outcomes of Fontan patients undergoing combined heart-liver transplantation in pediatric hospitals across the United States.
   J Thorac Cardiovasc Surg. 2026;171:288-297.
   PubMed     Abstract available
   
   
   December 2025
9. ZUBAIR MM, Shah AD, Veerakumar E, Shafqat S, et al
   Clinical Outcomes after COVID-19-Positive Donor Heart Transplantation in the United States Pediatric Population.
   J Thorac Cardiovasc Surg. 2025 Dec 26:S0022-5223(25)01121.
   PubMed     Abstract available
   
   
   
10. BERG AR, Krishnan A, Heng EE, Choi AY, et al
    Ex Vivo Heart Perfusion Offsets Ischemic Penalties with >/=6-Hour Preservation in Adult Donation-After-Brain-Death Heart Transplantation.
    J Thorac Cardiovasc Surg. 2025 Dec 6:S0022-5223(25)01047.
    PubMed     Abstract available
    
    
    October 2025
11. ALVAREZ A, Dewan KC, Milano CA, Jawitz OK, et al
    Outcomes Among Patients Bridged to Heart Transplant with Microaxial Flow Versus Durable Left Ventricular Assist Device Support.
    J Thorac Cardiovasc Surg. 2025 Oct 7:S0022-5223(25)00859.
    PubMed     Abstract available
    
    
    September 2025
12. HUNTERIA NELSON RP, Feng I, Vinogradsky AV, Barile J, et al
    Long-Term Outcomes Following Recovery from Severe Primary Graft Dysfunction After Heart Transplant.
    J Thorac Cardiovasc Surg. 2025 Sep 11:S0022-5223(25)00765.
    PubMed     Abstract available
    
    
    
13. HOZAIN AE, Johnson B, Leiva O, Hamzat I, et al
    Bloodless Heart Transplantation in Patients Who Refuse Transfusion: An 11-Year Case Series.
    J Thorac Cardiovasc Surg. 2025 Sep 9:S0022-5223(25)00764.
    PubMed     Abstract available
    
    
    
14. IGUIDBASHIAN J, Zakrzewski J, Lu L, Garcia AM, et al
    Targeted immunotherapy with sphingosine-1-phosphate improves myocardial contractility and mitochondrial function in a novel murine ex vivo perfusion and transplantation model.
    J Thorac Cardiovasc Surg. 2025;170:764-771.
    PubMed     Abstract available
    
    
    August 2025
15. BENKERT AR, Jawitz OK, Lobo AA, Casalinova S, et al
    Five-Year Experience of Heart Transplantation Following Donation After Circulatory Death.
    J Thorac Cardiovasc Surg. 2025 Aug 19:S0022-5223(25)00667.
    PubMed     Abstract available
    
    
    
16. WILLIAMS AM, Ahmad A, Bommareddi S, Lima B, et al
    Normothermic regional perfusion in donation after circulatory death compared with brain dead donors: Single-center cardiac allograft outcomes.
    J Thorac Cardiovasc Surg. 2025;170:585-593.
    PubMed     Abstract available
    
    
    June 2025
17. OVERBEY DM, Kucera JA, Aykut B, Wolf SE, et al
    Pediatric Heart Transplant in Donation After Circulatory Death using Normothermic Regional Perfusion.
    J Thorac Cardiovasc Surg. 2025 Jun 20:S0022-5223(25)00535.
    PubMed     Abstract available
    
    
    
18. GOERLICH CE, Wang CC, Trahanas J, Shirodkar S, et al
    Outcomes of Teenage Donor Hearts Transplanted into Adult Heart Transplant Recipients: A UNOS Analysis.
    J Thorac Cardiovasc Surg. 2025 Jun 7:S0022-5223(25)00469.
    PubMed     Abstract available
    
    
    May 2025
19. TOUBAT O, Bermudez CA
    Commentary: Understanding the impact of warm ischemia on donation after circulatory death heart transplant outcomes: getting warmer but not there yet.
    J Thorac Cardiovasc Surg. 2025 May 15:S0022-5223(25)00388.
    PubMed    
    
    
    April 2025
20. WANG CC, Petrovic M, Ahmad A, Navid W, et al
    The effect of warm ischemic intervals on primary graft dysfunction in normothermic regional perfusion for donation after circulatory death heart transplant.
    J Thorac Cardiovasc Surg. 2025 Apr 18:S0022-5223(25)00290.
    PubMed     Abstract available
    
    
    
21. MULLIS DM, Garrison A, Heng E, Zhu Y, et al
    Heart-liver transplantation using the en bloc technique: A single-center experience over two decades.
    J Thorac Cardiovasc Surg. 2025;169:1254-1262.
    PubMed     Abstract available
    
    
    March 2025
22. AYKUT B, Ghandour H, Mensah-Mamfo M, Ngeve SM, et al
    Partial heart transplant valves demonstrate growth in piglets despite prolonged cold storage.
    J Thorac Cardiovasc Surg. 2025 Mar 26:S0022-5223(25)00270.
    PubMed     Abstract available
    
    
    
23. 
    Commentator Discussion: Rise of the machines-Normothermic regional perfusion use in heart transplantation in the United States.
    J Thorac Cardiovasc Surg. 2025 Mar 15:S0022-5223(25)00110.
    PubMed    
    
    
    
24. RUCK JM, Rodriguez E, Zhou AL, Durand CM, et al
    For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C.
    J Thorac Cardiovasc Surg. 2025;169:932-940.
    PubMed     Abstract available
    
    
    February 2025
25. HONG Y, Hess NR, Ziegler LA, Chu D, et al
    Can we safely expand the donation after circulatory death donor heart pool by extending the donor age limit?
    J Thorac Cardiovasc Surg. 2025;169:658-666.
    PubMed     Abstract available
    
    
    December 2024
26. CHRISTOPHER KWON YI, Burmistrova M, Zhu DT, Lai A, et al
    The Impact of Donor Obesity on Outcomes of Donation After Circulatory Death Heart Transplantation.
    J Thorac Cardiovasc Surg. 2024 Dec 24:S0022-5223(24)01189.
    PubMed     Abstract available
    
    
    
27. GOUCHOE DA, Satija D, Cui EY, Schroder JN, et al
    Rise of the Machines - Normothermic Regional Perfusion Use in Heart Transplantation in the United States.
    J Thorac Cardiovasc Surg. 2024 Dec 9:S0022-5223(24)01122.
    PubMed     Abstract available
    
    
    
28. 
    Commentator Discussion: Early outcomes in heart transplantation using donation after circulatory death donors in patients bridged with durable left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024 Dec 7:S0022-5223(24)01027.
    PubMed    
    
    
    
29. PASRIJA C, Holmes SD, Rozenberg KS, Shah A, et al
    Right ventricular sizing and pulmonary vascular resistance: How much mass do you need?
    J Thorac Cardiovasc Surg. 2024;168:1712-1717.
    PubMed     Abstract available
    
    
    November 2024
30. 
    Commentator Discussion: The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024 Nov 12:S0022-5223(24)00922.
    PubMed    
    
    
    October 2024
31. GOODWIN ML, Nickel IC, Li H, Kagawa H, et al
    Direct Procurement with Machine Perfusion and Normothermic Regional Perfusion in Donation after Circulatory Death Heart Transplantation.
    J Thorac Cardiovasc Surg. 2024 Oct 25:S0022-5223(24)00984.
    PubMed     Abstract available
    
    
    
32. 
    Commentator Discussion: Survival, function, and immune profiling after beating heart transplantation.
    J Thorac Cardiovasc Surg. 2024 Oct 9:S0022-5223(24)00789.
    PubMed    
    
    
    September 2024
33. NORDAN T, Keshk M, Hackmann A, Givertz MM, et al
    The Impact of Blood Type and Body Size on Successful Bridging to Heart Transplantation using Intraaortic Balloon Pump or Surgically Implanted Microaxial Left Ventricular Assist Device.
    J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00835.
    PubMed     Abstract available
    
    
    
34. MOROI MK, Patel K, Rajesh K, Lin A, et al
    Early Outcomes in Heart Transplantation using Donation after Circulatory Death Donors in Patients Bridged with Durable Left Ventricular Assist Devices.
    J Thorac Cardiovasc Surg. 2024 Sep 9:S0022-5223(24)00788.
    PubMed     Abstract available
    
    
    
35. HEIMA D, Takeda M, Tabata Y, Minatoya K, et al
    Therapeutic potential of human induced pluripotent stem cell-derived cardiac tissue in an ischemic model with unloaded condition mimicking left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;168:e72-e88.
    PubMed     Abstract available
    
    
    August 2024
36. LASALA VR, Cordoves EM, Kalfa DM
    Adaptation of Cold Preservation Techniques to Partial Heart Transplant.
    J Thorac Cardiovasc Surg. 2024 Aug 20:S0022-5223(24)00697.
    PubMed    
    
    
    
37. KRISHNAN A, Elde S, Ruaengsri C, Guenthart BA, et al
    Survival, Function, and Immune Profiling after Beating Heart Transplantation.
    J Thorac Cardiovasc Surg. 2024 Aug 5:S0022-5223(24)00681.
    PubMed     Abstract available
    
    
    July 2024
38. KONSTANTINOV IE, Fricke TA
    Commentary: A paradigm change in surgical management of the apical hypertrophic cardiomyopathy to avoid heart transplantation.
    J Thorac Cardiovasc Surg. 2024 Jul 25:S0022-5223(24)00658.
    PubMed    
    
    
    
39. ZHOU AL, Rizaldi AA, Ruck JM, Akbar AF, et al
    Impact of Dual Thoracic Recovery from Circulatory Death Donors on Heart and Lung Transplant Outcomes.
    J Thorac Cardiovasc Surg. 2024 Jul 12:S0022-5223(24)00606.
    PubMed     Abstract available
    
    
    June 2024
40. 
    Discussion to: The majority of pediatric Fontan patients have excellent post-transplant survival.
    J Thorac Cardiovasc Surg. 2024;167:2204-2205.
    PubMed    
    
    
    
41. KULSHRESTHA K, Greenberg JW, Kennedy JT 3rd, Hogue S, et al
    The majority of pediatric Fontan patients have excellent post-transplant survival.
    J Thorac Cardiovasc Surg. 2024;167:2193-2203.
    PubMed     Abstract available
    
    
    
42. GUZMAN-GOMEZ A, Greenberg JW, Dani A, Villa C, et al
    In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
    J Thorac Cardiovasc Surg. 2024;167:2206-2214.
    PubMed     Abstract available
    
    
    May 2024
43. 
    Discussion to: Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1564-1565.
    PubMed    
    
    
    
44. KALFA D, Rajab TK, Cordoves E, Emani S, et al
    Living allogenic heart valve transplantation: Relative advantages and unanswered questions.
    J Thorac Cardiovasc Surg. 2024;167:1543-1546.
    PubMed    
    
    
    
45. GREENBERG JW, Kulshrestha K, Guzman-Gomez A, Fields K, et al
    Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1556-1563.
    PubMed     Abstract available
    
    
    
46. SIMPSON MT, Ning Y, Kurlansky P, Colombo PC, et al
    Outcomes of treatment for deep left ventricular assist device infection.
    J Thorac Cardiovasc Surg. 2024;167:1824-1832.
    PubMed     Abstract available
    
    
    April 2024
47. 
    Discussion to: Changes in heart transplant outcomes of elderly patients in the new allocation era.
    J Thorac Cardiovasc Surg. 2024 Apr 11:S0022-5223(24)00271.
    PubMed    
    
    
    
48. ALNAJAR A, Hirji S, Breda JR
    Commentary: Rethinking Heart Transplants in Septuagenarians - Is Age Just a Number?
    J Thorac Cardiovasc Surg. 2024 Apr 10:S0022-5223(24)00293.
    PubMed    
    
    
    
49. JEEVANANDAM V
    Commentary: Warm ischemic injury to human donor hearts-when is it too much?
    J Thorac Cardiovasc Surg. 2024;167:1361-1362.
    PubMed    
    
    
    
50. MONDAL NK, Li S, Elsenousi AE, Mattar A, et al
    Myocardial edema, inflammation, and injury in human heart donated after circulatory death are sensitive to warm ischemia and subsequent cold storage.
    J Thorac Cardiovasc Surg. 2024;167:1346-1358.
    PubMed     Abstract available
    
    
    
51. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
    A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;167:1322-1330.
    PubMed     Abstract available
    
    
    March 2024
52. 
    Discussion to: Four decades of progress in heart-lung transplantation: 271 cases at a single institution.
    J Thorac Cardiovasc Surg. 2024 Mar 25:S0022-5223(24)00182.
    PubMed    
    
    
    
53. SOLLIE ZW, Kwon JH, Usry B, Shorbaji K, et al
    Changes in Heart Transplant Outcomes of Elderly Patients in the New Allocation Era.
    J Thorac Cardiovasc Surg. 2024 Mar 20:S0022-5223(24)00269.
    PubMed     Abstract available
    
    
    
54. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
    Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
    PubMed     Abstract available
    
    
    
55. HONG Y, Hess NR, Ziegler LA, Hickey GW, et al
    Improved waitlist and comparable post-transplant outcomes in simultaneous heart-kidney transplantation under the 2018 heart allocation system.
    J Thorac Cardiovasc Surg. 2024;167:1064-1076.
    PubMed     Abstract available
    
    
    
56. AZIZGOLSHANI N, Takeda K
    Commentary: What is the destination after left ventricular assist device under the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:1060-1061.
    PubMed    
    
    
    
57. ZHANG A, Kurlansky P, Ning Y, Wang A, et al
    Outcomes following successful decannulation from extracorporeal life support for cardiogenic shock.
    J Thorac Cardiovasc Surg. 2024;167:1033-1046.
    PubMed     Abstract available
    
    
    February 2024
58. HUDDLESTON CB, Tan C
    Commentary: Heart-Lung Transplantation-Is It Worth It?
    J Thorac Cardiovasc Surg. 2024 Feb 27:S0022-5223(24)00183.
    PubMed    
    
    
    
59. ELDE S, Baccouche BM, Mullis DM, Leipzig MM, et al
    Four Decades of Progress in Heart-Lung Transplantation: 271 Cases at a Single Institution.
    J Thorac Cardiovasc Surg. 2024 Feb 4:S0022-5223(24)00100.
    PubMed     Abstract available
    
    
    
60. 
    Discussion to: Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:544-546.
    PubMed    
    
    
    
61. SINGH SK, Hassanein M, Ning Y, Wang C, et al
    Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:535-543.
    PubMed     Abstract available
    
    
    January 2024
62. ALEMANY VS, Nomoto R, Saeed MY, Celik A, et al
    Mitochondrial transplantation preserves myocardial function and viability in pediatric and neonatal pig hearts donated after circulatory death.
    J Thorac Cardiovasc Surg. 2024;167:e6-e21.
    PubMed     Abstract available
    
    
    
63. SONG TH, Salerno CT
    Commentary: Blood type O, a bigger problem in the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:241-242.
    PubMed    
    
    
    
64. ITAGAKI S, Toyoda N, Egorova N, Sun E, et al
    Total artificial heart implantation as a bridge to transplantation in the United States.
    J Thorac Cardiovasc Surg. 2024;167:205-214.
    PubMed     Abstract available
    
    
    December 2023
65. KIRSCHNER M, Topkara VK, Sun J, Kurlansky P, et al
    Comparing 3-Year Survival and Readmissions between HeartMate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure.
    J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01207.
    PubMed     Abstract available
    
    
    
66. VALDEOLMILLOS E, Le Pavec J, Audie M, Savale L, et al
    Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.
    J Thorac Cardiovasc Surg. 2023 Dec 3:S0022-5223(23)01121.
    PubMed     Abstract available
    
    
    
67. 
    Discussion to: Simultaneous heart-kidney transplant compared with heart transplant alone in patients with borderline renal function who are not dialysis dependent.
    J Thorac Cardiovasc Surg. 2023 Dec 2:S0022-5223(23)01088.
    PubMed    
    
    
    
68. TUME SC, Fuentes-Baldemar AA, Anders M, Spinner JA, et al
    Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.
    J Thorac Cardiovasc Surg. 2023;166:1756-1763.
    PubMed     Abstract available
    
    
    
69. THANGAPPAN K, Zafar F, Ahmed HF, Greenberg JW, et al
    Is the practice of using oversized organs for recipients with elevated pulmonary vascular resistance justified?
    J Thorac Cardiovasc Surg. 2023;166:1766-1779.
    PubMed     Abstract available
    
    
    
70. GANAPATHI AM, Heh V, Rosenheck JP, Keller BC, et al
    Thoracic retransplantation: Does time to retransplantation matter?
    J Thorac Cardiovasc Surg. 2023;166:1529-1541.
    PubMed     Abstract available
    
    
    November 2023
71. 
    Discussion to: Donation after circulatory death improves probability of heart transplantation in candidates with posttransplant outcomes similar to those achieved with brain-dead donors.
    J Thorac Cardiovasc Surg. 2023 Nov 3:S0022-5223(23)00971.
    PubMed    
    
    
    
72. WU Z, Miao X, Jiang Y, Kong D, et al
    Cardiomyocytic cyclic GMP-AMP synthase is critical for the induction of experimental cardiac graft rejection.
    J Thorac Cardiovasc Surg. 2023;166:e406-e427.
    PubMed     Abstract available
    
    
    October 2023
73. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    PubMed     Abstract available
    
    
    
74. SILVESTRY SC
    Commentary: The Evolving Market of Heart Transplantation.
    J Thorac Cardiovasc Surg. 2023 Oct 16:S0022-5223(23)00973.
    PubMed    
    
    
    
75. FENG I, Wang AS, Takeda K, Topkara VK, et al
    Simultaneous Heart-Kidney Transplant Compared to Heart Transplant Alone in Non-Dialysis Dependent Patients with Borderline Renal Function.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00960.
    PubMed     Abstract available
    
    
    
76. SCHUELER S, Bowles CT, Hinkel R, Wohlfarth R, et al
    A novel intrapericardial pulsatile device for individualized, biventricular circulatory support without direct blood contact.
    J Thorac Cardiovasc Surg. 2023;166:1119-1129.
    PubMed     Abstract available
    
    
    September 2023
77. HESS NR, Hong Y, Yoon P, Bonatti J, et al
    Donation After Circulatory Death Improves Probability of Heart Transplantation in Waitlisted Candidates and Results in Post-Transplant Outcomes Similar to Those Achieved with Brain Dead Donors.
    J Thorac Cardiovasc Surg. 2023 Sep 13:S0022-5223(23)00787.
    PubMed     Abstract available
    
    
    
78. BEATTIE MJ, Sleeper LA, Lu M, Teele SA, et al
    Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left hearts.
    J Thorac Cardiovasc Surg. 2023;166:933-942.
    PubMed     Abstract available
    
    
    July 2023
79. MONGE MC, Joong A
    Commentary: Bridging the gap with temporary ventricular assist devices in pediatrics.
    J Thorac Cardiovasc Surg. 2023;166:212-213.
    PubMed    
    
    
    June 2023
80. SCHRODER JN, Scheuer S, Catarino P, Caplan A, et al
    The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death.
    J Thorac Cardiovasc Surg. 2023 Jun 13:S0022-5223(23)00252.
    PubMed    
    
    
    
81. ELDE S, He H, Lingala B, Baiocchi M, et al
    Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    J Thorac Cardiovasc Surg. 2023;165:2090-2103.
    PubMed     Abstract available
    
    
    May 2023
82. SMERLING JL, Goldstone AB, Bacha EA, Liberman L, et al
    Long-term Outcomes of Tricuspid Valve Intervention During Stage 2 Palliation in Patients with a Single Right Ventricle.
    J Thorac Cardiovasc Surg. 2023 May 22:S0022-5223(23)00438.
    PubMed     Abstract available
    
    
    March 2023
83. LEI I, Tang PC
    Commentary: Draining the cGAS from Immunity, advancing heart transplant surgery through a translational science approach.
    J Thorac Cardiovasc Surg. 2023 Mar 16:S0022-5223(23)00249.
    PubMed     Abstract available
    
    
    
84. MANCINI D, Moss N
    Commentary: Bringing objectivity to the nonmedical evaluation of left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1123-1124.
    PubMed    
    
    
    
85. OLT CK, Thuita LW, Soltesz EG, Tong MZ, et al
    Value of psychosocial evaluation for left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1111-1121.
    PubMed     Abstract available
    
    
    
86. ROBERTSON G, Baran DA, Copeland H
    Commentary: In search of the "good candidate" for mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2023;165:1122-1123.
    PubMed    
    
    
    February 2023
87. ZAKKO J, Premkumar A, Logan AJ, Sneddon JM, et al
    Textbook outcome: A novel metric in heart transplantation outcomes.
    J Thorac Cardiovasc Surg. 2023 Feb 23:S0022-5223(23)00178.
    PubMed     Abstract available
    
    
    June 2022
88. SCHIAVON M, Camagni S, Venuta F, Rosso L, et al
    A multicentric evaluation of pediatric lung transplantation in Italy.
    J Thorac Cardiovasc Surg. 2022 Jun 20. pii: S0022-5223(22)00704.
    PubMed     Abstract available
    
    
    May 2022
89. BICHELL DP
    Commentary: The illogic of oversizing donor hearts for pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2022 May 11. pii: S0022-5223(22)00536.
    PubMed    
    
    
    September 2021
90. DUGGAL NM, Lei I, Wu X, Aaronson KD, et al
    Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01262.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Heart Transplantation is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum